Board of Directors
Swiss/German (born 1967)
Board member since 2021
Chair of the Board since 2024
Non-executive member, independent
Other main activities:
Member of the Board of V-Zug Holding (listed, Chair of Digital Advisory Board – until April 2026); SHL-Medical (Chair of the Audit Committee); Vimian (listed).
Key attributes for the Board:
Petra Rumpf is an exceptional industry insider with an excellent network. Her understanding of digital transformation journeys, changing consumer choices and emerging business models make her a great asset to the company.
Career highlights:
Petra Rumpf joined Straumann Group in 2015 as member of the Executive Management Board. As the Head Instradent & Strategic Alliances, she led the successful global expansion of the value brands and subsequently became the Global Head Dental Service Organizations in 2017. Before joining Straumann Group, she served on the Executive Committee of Nobel Biocare from 2007 to 2014, where she held several global leadership positions. During her 13 years as a member of executive boards in the dental industry, she incubated and managed global business units, defined and implemented digitally driven business models, provided strategic leadership and successfully delivered M&A and organic growth. Before joining the dental industry, she worked at Capgemini Consulting across several continents for 16 years and served as the Vice President Strategy & Transformation in the life science and high-tech sectors.
Qualifications:
Bachelor’s degree in economics from University of Trier; MBA in finance and investments from University of Clark.